Traws Pharma, Inc. — Director's Dealing 2020

Aug 31, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2020-08-27

Reporting Person: Hoffman Michael B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-27	Common Stock	S	182492	$0.2719	Disposed	21919	Indirect
2020-08-27	Common Stock	S	1876	$0.2719	Disposed	0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	564	Indirect

Footnotes

F1: These shares are held for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.